136 related articles for article (PubMed ID: 6128419)
1. Potential neuroleptic agents. 2,6-Dialkoxybenzamide derivatives with potent dopamine receptor blocking activities.
Florvall L; Ogren SO
J Med Chem; 1982 Nov; 25(11):1280-6. PubMed ID: 6128419
[TBL] [Abstract][Full Text] [Related]
2. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
Högberg T; Ström P; de Paulis T; Stensland B; Csöregh I; Lundin K; Hall H; Ogren SO
J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158
[TBL] [Abstract][Full Text] [Related]
3. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
Högberg T; de Paulis T; Johansson L; Kumar Y; Hall H; Ogren SO
J Med Chem; 1990 Aug; 33(8):2305-9. PubMed ID: 1973734
[TBL] [Abstract][Full Text] [Related]
4. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
Ogren SO; Hall H; Köhler C; Magnusson O; Florvall L
Arzneimittelforschung; 1985; 35(8):1227-31. PubMed ID: 2866774
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic properties of new N-(4-substituted-1-piperazinylethyl)- and N-(4-substituted-1-piperidinylethyl)-phthalimides.
al-Rashood KA; Mustafa AA; Alhaider AA; Ginawi OT; Madani AA; el-Obeid HA
J Pharm Sci; 1988 Oct; 77(10):898-901. PubMed ID: 2907047
[TBL] [Abstract][Full Text] [Related]
6. Potential neuroleptic agents. 2. Synthesis and dopamine blocking activity of some new 2,6-dimethoxybenzamide derivatives.
Florvall L; Persson ML; Ogren SO
Acta Pharm Suec; 1983; 20(5):365-70. PubMed ID: 6141698
[No Abstract] [Full Text] [Related]
7. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
Ogren SO; Hall H; Köhler C; Magnusson O; Lindbom LO; Angeby K; Florvall L
Eur J Pharmacol; 1984 Jul; 102(3-4):459-74. PubMed ID: 6149133
[TBL] [Abstract][Full Text] [Related]
8. Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.
Norman MH; Rigdon GC; Navas F; Cooper BR
J Med Chem; 1994 Aug; 37(16):2552-63. PubMed ID: 7914539
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and neuroleptic activity of N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-5-sulfonamidobenzamide s.
Ogata M; Matsumoto H; Kida S; Shiomi T; Eigyo M; Hirose K
J Med Chem; 1984 Sep; 27(9):1137-41. PubMed ID: 6147414
[TBL] [Abstract][Full Text] [Related]
10. Substituted benzamides with conformationally restricted side chains. 2. Indolizidine derivatives as central dopamine receptor antagonists.
King FD; Hadley MS; McClelland CM
J Med Chem; 1988 Sep; 31(9):1708-12. PubMed ID: 2900897
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
Van Ree JM; Elands J; Király I; Wolterink G
Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
[TBL] [Abstract][Full Text] [Related]
12. Neuropharmacological and behavioural properties of remoxipride in the rat.
Ogren SO; Florvall L; Hall H; Magnusson O; Angeby-Möller K
Acta Psychiatr Scand Suppl; 1990; 358():21-6. PubMed ID: 1978483
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and neuroleptic activity of a series of 1-[1-(benzo-1,4-dioxan-2-ylmethyl)-4-piperidinyl]benzim idazolone derivatives.
Henning R; Lattrell R; Gerhards HJ; Leven M
J Med Chem; 1987 May; 30(5):814-9. PubMed ID: 2883318
[TBL] [Abstract][Full Text] [Related]
14. Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides.
de Paulis T; Kumar Y; Johansson L; Rämsby S; Hall H; Sällemark M; Angeby-Möller K; Ogren SO
J Med Chem; 1986 Jan; 29(1):61-9. PubMed ID: 3941414
[TBL] [Abstract][Full Text] [Related]
15. 2-Phenylpyrroles as conformationally restricted benzamide analogues. A new class of potential antipsychotics. 2.
van Wijngaarden I; Kruse CG; van der Heyden JA; Tulp MT
J Med Chem; 1988 Oct; 31(10):1934-40. PubMed ID: 2902226
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
[TBL] [Abstract][Full Text] [Related]
17. Substituted benzamides as cerebral dopamine antagonists in rodents.
Elliott PN; Jenner P; Huizing G; Marsden CD; Miller R
Neuropharmacology; 1977 May; 16(5):333-42. PubMed ID: 559256
[No Abstract] [Full Text] [Related]
18. Psychotropic agents. 3. 4-(4-Substituted piperidinyl)-1-(4-fluorophenyl)-1-butanones with potent neuroleptic activity.
Sato M; Arimoto M; Ueno K; Kojima H; Yamasaki T; Sakurai T; Kasahara A
J Med Chem; 1978 Nov; 21(11):1116-20. PubMed ID: 31476
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of picobenzide (3,5-dimethyl-N-(pyridin-4-ylmethyl)benzamide) analogues as potential antipsychotic agents.
Gradillas A; López B; Braña MF; Sancho I; Pérez-García C; Alguacil LF
Arzneimittelforschung; 2005; 55(12):725-9. PubMed ID: 16430025
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of a series of substituted N-alkoxyimides and -amides as potential atypical antipsychotic agents.
Hrib NJ; Jurcak JG; Huger FP; Errico CL; Dunn RW
J Med Chem; 1991 Mar; 34(3):1068-72. PubMed ID: 1672156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
